Literature DB >> 12745924

Lipoplex size determines lipofection efficiency with or without serum.

Mohamad Radwan Almofti1, Hideyoshi Harashima, Yasuo Shinohara, Ammar Almofti, Wenhao Li, Hiroshi Kiwada.   

Abstract

In order to identify factors affecting cationic liposome-mediated gene transfer, the relationships were examined among cationic liposome/DNA complex (lipoplex)-cell interactions, lipoplex size and lipoplex-mediated transfection (lipofection) efficiency. It was found that lipofection efficiency was determined mainly by lipoplex size, but not by the extent of lipoplex-cell interactions including binding, uptake or fusion. In addition, it was found that serum affected mainly lipoplex size, but not lipoplex-cell interactions, which effect was the major reason behind the inhibitory effect of serum on lipofection efficiency. It was concluded that, in the presence or absence of serum, lipoplex size is a major factor determining lipofection efficiency. Moreover, in the presence or absence of serum, lipoplex size was found to affect lipofection efficiency by controlling the size of the intracellular vesicles containing lipoplexes after internalization, but not by affecting lipoplex-cell interactions. In addition, large lipoplex particles showed, in general, higher lipofection efficiency than small particles. These results imply that, by controlling lipoplex size, an efficient lipid delivery system may be achieved for in vitro and in vivo gene therapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12745924     DOI: 10.1080/09687680210035104

Source DB:  PubMed          Journal:  Mol Membr Biol        ISSN: 0968-7688            Impact factor:   2.857


  20 in total

1.  Mechanisms of lipoplex formation: dependence of the biological properties of transfection complexes on formulation procedures.

Authors:  V A Rakhmanova; E V Pozharski; R C MacDonald
Journal:  J Membr Biol       Date:  2004-07-01       Impact factor: 1.843

2.  Global gene expression profiling in cultured cells is strongly influenced by treatment with siRNA-cationic liposome complexes.

Authors:  Tatsuaki Tagami; Kiyomi Hirose; Jose Mario Barichello; Tatsuhiro Ishida; Hiroshi Kiwada
Journal:  Pharm Res       Date:  2008-06-26       Impact factor: 4.200

3.  Anionic liposomal delivery system for DNA transfection.

Authors:  Siddhesh D Patil; David G Rhodes; Diane J Burgess
Journal:  AAPS J       Date:  2004-10-15       Impact factor: 4.009

4.  An intracellular lamellar-nonlamellar phase transition rationalizes the superior performance of some cationic lipid transfection agents.

Authors:  Rumiana Koynova; Li Wang; Robert C MacDonald
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-18       Impact factor: 11.205

5.  Emerging links between surface nanotechnology and endocytosis: impact on nonviral gene delivery.

Authors:  Andrew F Adler; Kam W Leong
Journal:  Nano Today       Date:  2010-12-01       Impact factor: 20.722

6.  Silk-based gene carriers with cell membrane destabilizing peptides.

Authors:  Keiji Numata; David L Kaplan
Journal:  Biomacromolecules       Date:  2010-10-13       Impact factor: 6.988

Review 7.  Nanovehicular intracellular delivery systems.

Authors:  Ales Prokop; Jeffrey M Davidson
Journal:  J Pharm Sci       Date:  2008-09       Impact factor: 3.534

8.  Microporation is a valuable transfection method for efficient gene delivery into human umbilical cord blood-derived mesenchymal stem cells.

Authors:  Jung Yeon Lim; Sun Hwa Park; Chang Hyun Jeong; Ji Hyeon Oh; Seong Muk Kim; Chung Hun Ryu; Soon A Park; Jae Geun Ahn; Wonil Oh; Sin-Soo Jeun; Jong Wook Chang
Journal:  BMC Biotechnol       Date:  2010-05-13       Impact factor: 2.563

9.  Bioengineered silk protein-based gene delivery systems.

Authors:  Keiji Numata; Balajikarthick Subramanian; Heather A Currie; David L Kaplan
Journal:  Biomaterials       Date:  2009-07-04       Impact factor: 12.479

10.  Genetic correction of splice site mutation in purified and enriched myoblasts isolated from mdx5cv mice.

Authors:  Katie Maguire; Takayuki Suzuki; Darlise DiMatteo; Hetal Parekh-Olmedo; Eric Kmiec
Journal:  BMC Mol Biol       Date:  2009-02-23       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.